Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)

INR 24.21

(-0.62%)

Market Cap (In INR)

1.04 Billion

Revenue (In INR)

446.09 Million

Net Income (In INR)

-166.38 Million

Avg. Volume

229.96 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.41-87.55
PE
-
EPS
-
Beta Value
2.5188239
ISIN
INE994B01014
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Dhananjay Kumar Tiwary
Employee Count
-
Website
http://www.bibcol.com
Ipo Date
Details
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. The company was founded on March 10, 1989 and is headquartered in Bulandshahr, India.